Medtronic’s Infuse Bone Growth product was originally marketed as an innovative way to perform spinal fusion surgeries by using a genetically engineered protein to stimulate bone growth in the spine. However, nearly 85% of procedures using Infuse are now off-label – which is causing concern about who’s liable for its related injuries. Who’s Responsible for Infuse Injuries? According to a report by HealthWorks Collective, nearly 85% of procedures using Medtronic’s Infuse Bone Growth product are off-label – meaning they haven’t… Read More
Category: <span>Infuse Bone</span>
More and more patients are claiming that Medtronic’s Infuse Bone Growth doesn’t work and carries serious side effects. While patient lawsuits against the company are mounting, Medtronic shareholders are also angry. In a recently filed lawsuit, they claim that the company knew about the issues, but downplayed them to inflate stock prices. Medtronic Concealed Known Facts – From Everyone Minnesota based Medtronic, a global medical device company, has seen its share of scandals. In 2007, Medtronic’s Sprint Fidelis defibrillator lead… Read More
Medtronic’s Infuse Bone Graft has been found to work no better than traditional bone graft surgery. To make matters worse, it has also been linked to serious side effects such as cancer, sterility and infections – causing Infuse Bone Graft patients to question why more research wasn’t done before the product was put on the market. Risks May Outweigh Benefits According to the Bloomberg News, although Medtronic’s Infuse Bone Graft was designed to help bones heal after spinal surgery, its… Read More
A recent article in The New England Journal of Medicine raises concerns about how long women at risk of osteoporosis should take bone-building drugs such as Fosamax. Fosamax is among a group of drugs known as bisphosphonates that are widely prescribed for osteoporosis, a disease characterized by increasing bone fragility and low bone density. The concern flagged in the systematic review by the Food and Drug Administration is that bone-building drugs may in rare cases lead to weaker bones in… Read More
